128 related articles for article (PubMed ID: 37245991)
1. Susceptibility to adriamycin-induced hepatotoxicity in mice depends on PRKDC polymorphism.
Watanabe M; Kakutani M; Ando R; Hiura K; Sasaki H; Okamura T; Sasaki N
J Vet Med Sci; 2023 Jul; 85(7):702-704. PubMed ID: 37245991
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in PRKDC is a determinant of sensitivity to Adriamycin-induced renal injury in mouse.
Watanabe M; Takahashi Y; Hiura K; Nakano K; Okamura T; Sasaki H; Sasaki N
Biochem Biophys Res Commun; 2021 Jun; 556():121-126. PubMed ID: 33839407
[TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of a Novel FVB-
Watanabe M; Ishii Y; Hashimoto K; Takimoto HR; Sasaki N
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674390
[TBL] [Abstract][Full Text] [Related]
4. Genetic background strongly influences the transition to chronic kidney disease of adriamycin nephropathy in mice.
Watanabe M; Hiura K; Sasaki H; Okamura T; Sasaki N
Exp Anim; 2023 Feb; 72(1):47-54. PubMed ID: 36058845
[TBL] [Abstract][Full Text] [Related]
5. Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.
Papeta N; Zheng Z; Schon EA; Brosel S; Altintas MM; Nasr SH; Reiser J; D'Agati VD; Gharavi AG
J Clin Invest; 2010 Nov; 120(11):4055-64. PubMed ID: 20978358
[TBL] [Abstract][Full Text] [Related]
6. Differences in susceptibility to ADR nephropathy among C57BL/6 substrains.
Watanabe M; Kakutani M; Hiura K; Sasaki H; Sasaki N
Exp Anim; 2023 Nov; 72(4):520-525. PubMed ID: 37344407
[TBL] [Abstract][Full Text] [Related]
7. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
8. Murine Prkdc polymorphisms impact DNA-PKcs function.
Fabre KM; Ramaiah L; Dregalla RC; Desaintes C; Weil MM; Bailey SM; Ullrich RL
Radiat Res; 2011 Apr; 175(4):493-500. PubMed ID: 21265624
[TBL] [Abstract][Full Text] [Related]
9. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of methyl jasmonate against adriamycin--induced hepatic and renal toxicities.
Kosoko AM; Molokwu CJ; Farombi EO; Ademowo OG
Afr J Med Med Sci; 2012 Dec; 41 Suppl():117-24. PubMed ID: 23678646
[TBL] [Abstract][Full Text] [Related]
11. Nitro-oleic acid protects against adriamycin-induced nephropathy in mice.
Liu S; Jia Z; Zhou L; Liu Y; Ling H; Zhou SF; Zhang A; Du Y; Guan G; Yang T
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1533-41. PubMed ID: 23486011
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
Wang C; Li Q; Zhen J; Xu Y; Sun S
Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
[TBL] [Abstract][Full Text] [Related]
13. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene.
Yu Y; Okayasu R; Weil MM; Silver A; McCarthy M; Zabriskie R; Long S; Cox R; Ullrich RL
Cancer Res; 2001 Mar; 61(5):1820-4. PubMed ID: 11280730
[TBL] [Abstract][Full Text] [Related]
14. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity.
Huang X; Xue H; Ma J; Zhang Y; Zhang J; Liu Y; Qin X; Sun C
J Cell Mol Med; 2019 Jun; 23(6):4443-4453. PubMed ID: 30993911
[TBL] [Abstract][Full Text] [Related]
15. Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy.
Kim DR; Lee SY; Kim JS; Kim YG; Moon JY; Lee SH; Lee TW; Ihm CG; Jeong KH
Biomed Res Int; 2017; 2017():7275109. PubMed ID: 28326327
[No Abstract] [Full Text] [Related]
16. Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis.
Takiue K; Sugiyama H; Inoue T; Morinaga H; Kikumoto Y; Kitagawa M; Kitamura S; Maeshima Y; Wang DH; Masuoka N; Ogino K; Makino H
BMC Nephrol; 2012 Mar; 13():14. PubMed ID: 22443450
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
18. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities.
Hou XW; Jiang Y; Wang LF; Xu HY; Lin HM; He XY; He JJ; Zhang S
Toxicol Lett; 2009 May; 187(1):40-4. PubMed ID: 19429242
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
20. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
Marshall CB; Krofft RD; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
